search icon
  • Print
  • ShareThis
  • Text Size

Stanford University

Stanford University

Division of Infectious Diseases
300 Pasteur Drive, Grant S-169

Palo Alto, CA  94305-5107

Phone: 650 723 7912
Fax: 650 723 3474

Training Program Director

Brian Blackburn MD    

Research Interests: 

Participating Hospitals

  • Stanford University : 594
  • VA Palo Alto Health Care System : 903
  • Santa Clara Valley Medical Center : 324

Program Training Offerings

How does this program meet the ABIM requirements for training in clinical microbiology?

Didactic Lectures
Hands-on Experience

The Program provides training in hospital epidemiology through:

Didactic Lectures
Continuity Clinic
Hands-on Experiences

The Program provides clinical experience for fellows in the following:

Infections in marrow transplant
Infections in solid organ transplant patients
Infections in travelers and tropical medicine
Infections in children

This Program provides training in STD management through:

Didactic Lectures

The Program has a didactic lecture course for fellows:


If yes, what is the average number of lectures provided over a two-year period?


Training is for:


Are there citizenship requirements?


Types of visas accepted:

Number of fellows accepted each year:


Duration of the Fellowship (years):


The Program has a training grant (T32):


Average number of infectious diseases consults per trainee per year:


Number of Fellows completing the Program in the last 5 years:


Additional Training/Faculty Resources (optional):

Clinical Educator Track

Clinical Investigator Track

Basic Investigator Track 



Applications accepted via Electronic Residency Application Service (ERAS®)?


Timeframe when applications are accepted:

Timeframe when interviews are done


Lucy S. Tompkins , MD, PhD , Prof.

Research Interests: Dr. Tompkins' areas of research include the cellular, molecular, and genetic basis of pathogenicity and host-pathogen interactions of Helicobacter pylori and clinical and molecular epidemiology of nosocomial infections


Mark Holodniy , MD , Prof.

Research Interests: Dr. Holodniy has over 10 years of experience in the laboratory and clinical evaluation of molecular diagnostic and therapeutic monitoring assays, which include antiretroviral resistance assays.

David A. Katzenstein , MD , Assoc. Prof.

Research Interests: Dr. Katzenstein is the Principal Investigator for the Stanford Virology Laboratory where the primary interests are the pathogenesis and treatment of Human Immunodeficiency Virus. Laboratory work has been integrated with clinical trials of antiretrovirals, immune modulators, cytokines and vaccines in an effort to understand the virologic and immunologic responses to HIV and a variety of treatment modalities through studies of primary patient material and viruses obtained from phase 1-3 trials. In addition, the laboratory participates in studies of KSHV and other Herpes Viruses.

Julie Parsonnet , MD , Assoc. Prof.

Research Interests: Dr. Parsonnet's primary research interest is in enteric bacterial infections. Over time, this interest has evolved to include interactions among these infectious agents and their role in causing chronic disease. Much of this work has revolved around Helicobacter pylori infection as a cause of adenocarcinomas and lymphomas of the stomach. Other chronic disease-infection links that Dr. Parsonnet has investigated are atherosclerosis and colon cancer. Dr. Parsonnet continues to study diarrheal diseases in the U.S. and overseas and has also worked on devising economically sound strategies for vaccine development.

Jack S. Remington , MD , Prof.

Research Interests: Dr. Remington’s group has focused on mechanisms of host resistance against opportunistic pathogens, with special emphasis on Toxoplasma gondii and toxoplasmosis. Since the beginning of the epidemic of AIDS, Dr. Remington’s laboratory has worked on the immunopathogenesis of toxoplasmic encephalitis, particularly the roles of cellular immunity and cytokines. At present, his group is concentrating on both diagnosis and treatment of the infection in immunologically normal and immunologically impaired individuals. In addition, Dr. Remington’s research program is focusing on the effects of antibiotics on the immune response.

Gary K. Schoolnik , MD , Prof.

Research Interests: Dr. Schoolnik's interests are in the pathogenicity ofMycobacterium tuberculosis and enteropathogenicE. coli, and in the persistence of Vibrio cholerae within aquatic environmental habitats. He employs a combination of genetic, biochemical and physiological methods to pursue these interests.

Robert Shafer , MD , Asst. Prof.

Research Interests: Dr. Shafer's research is on the mechanisms and consequences of HIV evolution within human populations. The main focus of the research is on the development of HIV antiretroviral drug resistance.

Nancy Shulman , MD , Instructor

Research Interests: Dr. Shulman's area of expertise is HIV therapeutics, particularly antiretroviral resistance. She was awarded an NIH grant to study the mechanisms of NNRTI hypersusceptibility. Her other research/clinical interests include: HCV, HIV/HCV co-infection and HIV in women.

David A. Stevens , MD , Prof.

Research Interests: Dr. Steven’s laboratory focuses on the study of pathogenic fungi. The different areas of study include biology of fungi, pathogenesis of how fungi cause disease, host mechanisms of resistance to fungal infections, epidemiology of fungal infections and laboratory or clinical testing of approved as well as experimental drugs for the treatment of fungal infections.

Dean Winslow , MD

Research Interests: Dr. Winslow's professional interests at present are focused on patient care and clinical teaching, and serving as a mentor for infectious disease fellows who are interested in pursuing careers in clinical research and clinical practice. Chief of the Division of AIDS Medicine and Director of the PACE Clinic at the Santa Clara Valley Medical Center.

Andrew Zolopa , MD , Asst. Prof.

Research Interests: In his research activities Dr. Zolopa applies a variety of clinical epidemiologic methods in an effort to optimize antiretroviral therapy. Areas of focus include the clinical application of resistance testing in optimizing antiretroviral therapy, clinical cohort and trials of antiretroviral therapies and population-based epidemiologic evaluation of HIV resistance and efficacy of ARV therapy in urban poor communities of San Francisco.

Average 0 out of 5

| HIVMA | Contact Us

© Copyright IDSA 2018 Infectious Diseases Society of America

Full Site Mobile Site